Routine home blood pressure monitoring (HBPM) may help the 73 million individuals with hypertension better manage the disease, according to a new joint scientific statement from 3 health care organizations.
The target HBPM goal for treatment is <135/85 mm Hg or <130/80 mm Hg in high-risk patients. Home monitoring is useful in the elderly—in whom both BP variability and the white-coat effect are increased—patients with diabetes, patients with kidney disease, and in pregnant women, according to the statement.
"Blood pressure measurement and tracking could be improved with home monitoring by the patients themselves, in much the way people with diabetes monitor their blood sugar levels with home glucose monitors," said Thomas G. Pickering, MD, PhD, chair of the statement writing group.
Studies have pointed out that the traditional way of measuring BP in adults can be misleading. Research has shown that between 10% and 20% of patients diagnosed with high BP in the physician's office actually have the white-coat effect, meaning that their pressures are within normal range under other conditions, but spike in the medical setting.
Because BP changes throughout the day, taking one reading at a physicians office every few months does not give an accurate assessment of an individual's condition. Dr. Pickering noted several benefits of home monitor use. Home monitors can take multiple measurements during each session, can be used at different times of the day, and will help to involve patients in the management of their own BP. Many home monitors are equipped to store average BP readings over time, providing key data for patients to take to their physicians so they can work together to diagnose and treat the condition. As for cost, many monitors retail for under $100.
As for the current use of HBPM, the researchers highlighted several key results from a Gallup poll of patients with hypertension conducted in 2005. The number of patients monitoring their BP at home has rose steadily over the past 5 years, being 38% in 2000 and 55% in 2005. The proportion of patients owning a monitor has increased from 49% in 2000 to 64% in 2005. In 2000, 35% of patients reported that a physician recommended the use of a home monitor, and rose to 47% in 2005.
Pharmacists are considered the most accessible health care provider. Because home BP monitors are typically sold at community pharmacies, and patients visit their pharmacy monthly to pick up their antihypertensive medication, pharmacists can play a key role in recommending HBPM and how to properly use the machine.
Although earlier AHA guidelines have included home monitors, this is the first statement to have detailed recommendations on their use. They include:
The statement was published recently online in Hypertension, the Journal of the American Society of Hypertension, the Journal of Clinical Hypertension, and in the June 2008 issue of the Journal of Cardiovascular Nursing.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs